ArticleNPJ precision oncology2022

Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy.

Albert Manzano-Muñoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.